Company News

Philips healthcare presents MyoStrain at RSNA 2020

December 8, 2020

Presentation: Philips Healthcare Presents MyoStrain® at RSNA 2020

Philips Healthcare presented MyoStrain® at RSNA 2020 and discussed how MyoStrain's MRI-based cardiac diagnostic solutions may help transform cardiovascular care and enable physicians to quantify subtle changes in intra-myocardial heart function.

Read more >
MyoStrain Featured at VCOS 2020 Satellite Symposium

October 8, 2020

Myocardial Solutions Sponsors Featured MyoStrain® Satellite Symposium at 2020 Virtual Cardio-Oncology Summit (V-COS)

Myocardial Solutions (MSI) featured MyoStrain® in a satellite symposium at the first ever International Cardio-Oncology Summit 2020, a joint CardioTox and Global Cardio-Oncology Society (GCOS) initiative attracting oncologists, cardiologists, radiologists and pharmacists from around the world to ...

Read more >

September 24, 2020

Society for Cardiovascular Magnetic Resonance Recommends MyoStrain® in New CMR-Protocols for Identifying Cardiac Damage in COVID-19 Patients

MyoStrain® was included in a new article published in the Journal of Cardiovascular Magnetic Resonance (JCMR) by the Society of Cardiovascular Magnetic Resonance (SCMR). The paper provides specific and detailed recommendations on the use of cardiovascular magnetic resonance (CMR) protocols for...

Read more >

September 8, 2020

Five New Abstracts, Poster Presentations Featuring MyoStrain® Presented at European Society of Cardiology Congress 2020

Myocardial Solutions (“MSI”) technology MyoStrain® was featured in five unique abstracts and e-poster presentations at the European Society of Cardiology (ESC) virtual congress event from August 29th to September 2nd. The abstracts discussed the diagnostic value and clinical impact of MyoStrain...

Read more >

August 20, 2020

Myocardial Solutions Awarded Most Innovative Cardiology Software Company 2020

Myocardial Solutions, Inc. (“MSI”) was recognized as the Most Innovative Cardiology Software Company of 2020.The award to MSI was published in Acquisition International’s (“AI Global”) annual Global Excellence Awards issue for the month of August. AI Global is a magazine publisher based in the...

Read more >

August 11, 2020

Myocardial Solutions Announces Strategic Partnership with United Imaging, Bringing Rapid Cardiac MR Imaging to Unmet Cancer Care and Cardiology Markets

Myocardial Solutions, Inc. (“MSI”) and United Imaging, Inc. (“United Imaging”) have formed a strategic partnership to open the cancer care and cardiology market for rapid imaging enabling the detection and management of cardiac diseases and the effects of cancer therapies on the heart...

Read more >

June 23, 2020

Myocardial Solutions Announces New CMS Codes Dedicated to Proprietary MyoStrain® and MyoStress™ Testing

Myocardial Solutions, Inc. (MSI), who has pioneered the quantification of segmental cardiac strain testing to transform how physicians manage and monitor patient heart health, announced today that the Centers for Medicare and Medicaid Services (CMS) has issued unique codes for MSI’s...

Read more >
Blurred light stretches along windy, mountainous road

May 28, 2020

Myocardial Solutions Named Top 50 Most Innovative Companies to Watch in 2020

Myocardial Solutions, Inc. (MSI) was recognized in an article published by the CEO Views describing their selection for the “Most Innovative Companies to Watch in 2020” yearly list. The list highlights companies driving innovative technology solutions to challenge and transform the current ...

Read more >
A physician types on a laptop

April 25, 2020

New ESC Webinar Highlights MyoStrain® Cardio-Oncology Solution for the Early Detection & Management of Cancer Patient Cardiotoxicity

MyoStrain® was featured in the European Society of Cardiology’s (ESC) cardio-oncology webinar series to examine the role of MyoStrain in helping cardio-oncologists manage cardiac health for patients undergoing cancer therapy. As part of an educational grant sponsored by Myocardial Solutions...

Read more >
peter gaccione joins myocardial solutions as president

April 21, 2020

Peter Gaccione Joins Myocardial Solutions as President to Lead Commercialization of Cardio-Oncology Solution

Myocardial Solutions, Inc. announced today that it has hired Peter Gaccione as President effective April 13, 2020. Peter will also serve as acting VP Sales and Marketing to drive focus and increase market penetration efforts. Peter comes from Elekta where he was EVP North & Central America and...

Read more >